Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT06540508 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences